229
Views
9
CrossRef citations to date
0
Altmetric
In vitro and animal studies

Effects of eicosapentaenoic acid on hepatic dyslipidemia and oxidative stress in high fat diet-induced steatosis

, , , &
Pages 569-573 | Received 21 Jan 2015, Accepted 16 Apr 2015, Published online: 28 May 2015

References

  • Abete I, Goyenechea E, Zulet MA, Martínez JA. 2011. Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutr Metab Cardiovasc Dis 21:B1–B15
  • Assy N. 2011. Nutritional recommendations for patients with non-alcoholic fatty liver diseases. World J Gastroenterol 17:3375–3376
  • Băloşeanu CL, Streba CT, Vere CC, Comănescu V, Rogoveanu I. 2012. Association between liver histology, carotid ultrasonography and retinal vascular changes in patients with nonalcoholic fatty liver disease (NAFLD). Rom J Morphol Embryol 53:609–614
  • Chapkin RS, Kim W, Lupton JR, McMurray DN. 2009. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids 81:187–191
  • Di Minno MND, Russolillo A, Lupoli R, Ambrosino P, Di Minno A, Tarantino G. 2012. Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. World J Gastroenterol 18:5839–5847
  • Espinosa A, Valenzuela R, González-Mañán D, D'Espessailles A, Guillermo Gormaz J, Barrera C, Tapia G. 2013. Prevention of liver steatosis through fish oil supplementation: correlation of oxidative stress with insulin resistance and liver fatty acid content. Arch Latinoam Nutr 63:29–36
  • Folch J, Lees M, Sloane Stanley GH. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497–509
  • González-Périz A, Horrillo R, Ferré N, Gronert K, Dong B, Morán-Salvador E, Titos E, et al. 2009. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J 23:1946–1957
  • Haimeur A, Ulmann L, Mimouni V, Guéno F, Pineau-Vincent F, Meskini N, Tremblin G. 2012. The role of Odontella aurita, a marine diatom rich in EPA, as a dietary supplement in dyslipidemia, platelet function and oxidative stress in high-fat fed rats. Lipids Health Dis 11:147–159
  • Jump DB. 2008. N−3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr Opin Lipidol 19:242–247
  • Kalupahana NS, Claycombe K, Newman SJ, Stewart T, Siriwardhana N, Matthan N, Lichtenstein AH, Moustaid-Moussa N. 2010. Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. J Nutr 140:1915–1922
  • Oliveira CP, Coelho AM, Barbeiro HV, Lima VM, Soriano F, Ribeiro C, Molan NA, et al. 2006. Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease. Braz J Med Biol Res 39:189–194
  • Perez-Martinez P, Perez-Jimenez F, Lopez-Miranda J. 2010. n−3 PUFA and lipotoxicity. Biochim Biophys Acta 1801:362–366
  • Pérez-Matute P, Pérez-Echarri N, Martínez JA, Marti A, Moreno-Aliaga MJ. 2007. Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-alpha. Br J Nutr 97:389–398
  • Popescu LA, Vîrgolici B, Lixandru D, Miricescu D, Condruţ E, Timnea O, Ranetti AE, et al. 2013. Effect of diet and omega-3 fatty acids in NAFLD. Rom J Morphol Embryol 54:785–790
  • Quiroga AD, Li L, Trötzmüller M, Nelson R, Proctor SD, Köfeler H, Lehner R. 2012. Deficiency of carboxylesterase 1/esterase-x results in obesity, hepatic steatosis, and hyperlipidemia. Hepatology 56:2188–2198
  • Robbez Masson V, Lucas A, Gueugneau AM, Macaire JP, Paul JL, Grynberg A, Rousseau D. 2008. Long-chain (n−3) polyunsaturated fatty acids prevent metabolic and vascular disorders in fructose-fed rats. J Nutr 138:1915–1922
  • Saraswathi V, Morrow JD, Hasty AH. 2009. Dietary fish oil exerts hypolipidemic effects in lean and insulin sensitizing effects in obese LDLR−/− mice. J Nutr 139:2380–2386
  • Shapiro H, Tehilla M, Attal-Singer J, Bruck R, Luzzatti R, Singer P. 2011. The therapeutic potential of long-chain omega−3 fatty acids in nonalcoholic fatty liver disease. Clin Nutr 30:6–19
  • Shirouchi B, Nagao K, Inoue N, Ohkubo T, Hibino H, Yanagita T. 2007. Effect of dietary omega 3 phosphatidylcholine on obesity-related disorders in obese Otsuka Long-Evans Tokushima fatty rats. J Agric Food Chem 55:7170–7176
  • Szalman K, Bancu L, Sin A. 2013. Correlations between anthropometric and serologic elements of metabolic syndrome and histopathologic features of nonalcoholic fatty liver disease. Rom J Morphol Embryol 54:173–178
  • Tillander V, Bjørndal B, Burri L, Bohov P, Skorve J, Berge RK, Alexson SE. 2014. Fish oil and krill oil supplementations differentially regulate lipid catabolic and synthetic pathways in mice. Nutr Metab (Lond) 11:20
  • Valenzuela R, Espinosa A, González-Mañán D, D'Espessailles A, Fernández V, Videla LA, Tapia G. 2012. N−3 long-chain polyunsaturated fatty acid supplementation significantly reduces liver oxidative stress in high fat induced steatosis. PLoS One 7:1–8
  • Valenzuela R, Videla LA. 2011. The importance of the long-chain polyunsaturated fatty acid n−6/n−3 ratio in development of non-alcoholic fatty liver associated with obesity. Food Funct 2:644–648
  • Yanagita T, Nagao K. 2008. Functional lipids and the prevention of the metabolic syndrome. Asia Pac J Clin Nutr 17:189–191

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.